Malignant Breast Lump: To Classify It Based on clinico-demographic Features and To Assess the Correlation Between Tumor Size and Axillary Lymph Node Positivity

Maryam  Basharat; Muhammad  Imran Anwar

doi:10.54112/bcsrj.v6i1.1471

Authors

Maryam Basharat Department of General Surgery and Surgical Oncology, Shaikh Zayed Hospital Lahore, Pakistan
Muhammad Imran Anwar Department of General Surgery and Surgical Oncology, Shaikh Zayed Hospital Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i1.1471

Keywords:

Breast Neoplasms Axillary Lymph Nodes Lymphatic Metastasis Carcinoma, Ductal, Breast Survival Rate

Abstract

Breast cancer is a leading cause of mortality in females, accounting for approximately 25% of all breast cancers and contributing to 15% of cancer-related deaths in women. Infiltrating ductal carcinoma is the most common histological type, with axillary lymph node involvement being a critical prognostic factor, particularly in early breast cancer. Objective: To evaluate the relationship between tumor characteristics, size and consistency, and axillary lymph node involvement in breast cancer patients. Methods: This observational cross-sectional study was conducted in the General Surgery and Surgical Oncology Unit of Shaikh Zayed Hospital, Lahore. A total of 165 patients were included using a non-probability consecutive sampling technique. Demographic and clinical data were collected, including tumor size, laterality, site, and consistency, and their relationship with axillary lymph node positivity was analyzed. Results: The mean age of patients was 45.45 ± 6.31 years, and the mean size of malignant breast lumps was 3.57 ± 0.84 cm. Most tumors (88.48%) measured 2-5 cm, while tumors >5 cm and <2 cm accounted for 7.28% and 4.24%, respectively. Left-sided breast lumps were more common (55.15%) than right-sided lumps (44.85%). Tumor size and consistency were significantly associated with axillary lymph node positivity, with p-values <0.05. Conclusion: Axillary lymph node involvement remains an independent risk factor for breast cancer prognosis. Tumor size and consistency are strongly associated with the number of positive lymph nodes, emphasizing their role in the clinical evaluation and management of breast cancer.

Downloads

Download data is not yet available.

References

Lacey Jr JV, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environmental and molecular mutagenesis. 2002;39(2‐3):82-8.

Li C, Uribe Da, Daling J. Clinical characteristics of different histologic types of breast cancer. British journal of cancer. 2005;93(9):1046-52.

Russo J, Frederick J, Ownby HE, Fine G, Hussain M, Krickstein HI, et al. Predictors of recurrence and survival of patients with breast cancer. American journal of clinical pathology. 1987;88(2):123-31.

Kumar R, Abreu C, Toi M, Saini S, Casimiro S, Arora A, et al. Oncobiology and treatment of breast cancer in young women. Cancer and Metastasis Reviews. 2022;41(3):749-70.

You JY, Park S, Lee E-G, Lee ES. Detection and Diagnosis of Breast Cancer. A Practical Guide to Breast Cancer Treatment: Springer; 2023. p. 1-17.

Krum-Hansen S. A Systems Epidemiology Approach to Breast Cancer and Parity. The Norwegian Women and Cancer (NOWAC) Study. 2024.

Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. Journal of clinical oncology. 1999;17(8):2334-.

Patani N, Dwek M, Douek M. Predictors of axillary lymph node metastasis in breast cancer: a systematic review. European Journal of Surgical Oncology (EJSO). 2007;33(4):409-19.

Veronesi U, Galimberti V, Zurrida S, Merson M, Greco M, Luini A. Prognostic significance of number and level of axillary node metastases in breast cancer. The Breast. 1993;2(4):224-8.

Chopra B, Kaur V, Singh K, Verma M, Singh S, Singh A. Age shift: Breast cancer is occurring in younger age groups-Is it true. Clin Cancer Investig J. 2014;3(6):2278-0513.142652.

El-Tamer MB, Wait RB. Age at presentation of African-American and Caucasian breast cancer patients. Journal of the American College of Surgeons. 1999;188(3):237-40.

Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound. A retrospective review. Cancer. 1995;76(4):626-30.

Chand P, Singh S, Singh G, Kundal S, Ravish A. A study correlating the tumor site and size with the level of axillary lymph node involvement in breast cancer. Nigerian Journal of Surgery. 2020;26(1):9-15.

Abeysuriya V, Chandrasena L. Clinical and histological characteristics of breast lumps: A 20-year single private sector tertiary care center experience. Journal of the Postgraduate Institute of Medicine. 2023;10(2):1-7.

Omer AM, Alrehili NA, Almughamsi RK, Aljurfi HM, Setaih HS, Gareeballah A, et al. Characterization of breast lumps locations using high-frequency ultrasound: Correlation between Doppler vascularity and BI-RADS. Journal of Radiation Research and Applied Sciences. 2023;16(4):100661.

Chan S, Chen J-H, Li S, Chang R, Yeh D-C, Chang R-F, et al. Evaluation of the association between quantitative mammographic density and breast cancer occurred in different quadrants. BMC cancer. 2017;17:1-11.

Al Saad S, Al Shenawi H, Almarabheh A, Al Shenawi N, Mohamed AI, Yaghan R. Is laterality in breast Cancer still worth studying? Local experience in Bahrain. BMC cancer. 2022;22(1):968.

Koto M, Becker J, Mokone-Fatunla D, Mundawarara S, Bondo M. Laterality of breast cancer at Dr George Mukhari academic hospital. South African Journal of Surgery. 2019;57(3):55-61.

Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181-7.

Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;98(10):2133-43.